Incannex Healthcare (IXHL) Receivables (2020 - 2023)
Incannex Healthcare (IXHL) posted quarterly Receivables of $287478.0 for Q2 2023, down 2.46% year-on-year from $294717.0 in Q2 2022, and down 36.09% on a QoQ basis from $449843.0 in Q4 2022.
Incannex Healthcare (IXHL) Receivables (2020 - 2023) Analysis & Trends
Incannex Healthcare (IXHL) has reported Receivables for 4 consecutive years, with $287478.0 the latest figure, recorded in Q2 2023.
- Quarterly Receivables fell 2.46% year-over-year to $287478.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $287478.0 (down 2.46% YoY) and the FY2023 annual result came in at $287478.0, down 2.46% from the prior year.
- Receivables declined to $287478.0 in Q2 2023 per IXHL's latest filing, from $449843.0 in the prior quarter.
- Over the last five years, Receivables for IXHL reached as high as $449843.0 in Q4 2022 and fell as low as $222535.0 in Q2 2021.
- A 4-year average of $333568.2 and a median of $294717.0 in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables slumped 46.15% — and 2022, when it soared 32.44%.
- Year by year, Receivables stood at $413268.0 in 2020, then sank by 46.15% to $222535.0 in 2021, then soared by 102.14% to $449843.0 in 2022, then tumbled by 36.09% to $287478.0 in 2023.
- According to Business Quant data, Receivables over the past three periods registered $287478.0, $449843.0, and $294717.0 for Q2 2023, Q4 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 287,478.00 |
| Dec 31, 2022 | 449,843.00 |
| Jun 30, 2022 | 294,717.00 |
| Jun 30, 2021 | 222,535.00 |
| Jun 30, 2020 | 413,268.00 |